Uganda 'To Begin Human Trials' Of Covid-19 Vaccine
Uganda will begin human trials of a Covid-19 vaccine in November, the Daily Monitor newspaper reports quoting the ministry of health officials.
The vaccine, called Self Replicating RNA, has been developed through a partnership between Uganda Virus Research Institute (UVRI) and Imperial College in the UK.
The head of a presidential taskforce on epidemics, Monica Musenero, is quoted as saying the first trial will be conducted on 10 Ugandans.
If successful, a second trial will involve about 100 to 200 people followed by a final trial of between 1,000 and 3,000 people, she said.
The bulk of the project is being financed by the UK university.
<<Print>>